PRO 140: Phase IIb start

Next half, CytoDyn said Drexel University College of Medicine will begin the placebo-controlled, U.S. Phase IIb NIDA and NIAID trials of PRO 140 to treat HIV infection. NIDA will evaluate PRO 140 in c...